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Methods 
 
Determining front velocity in the absence of flow. For experiments in the absence of 
flow in PDMS channels, recalcified blood plasma (final [CaCl2] = 10 mM) containing a 
thrombin-sensitive, peptide-modified fluorescent dye, Boc-Asp(OBzl)-Pro-Arg-MCA 
(100 AM), was flowed into the device from the inlet where egg phosphatidylcholine (Egg 
PC) was flowed in.  Recalcified blood plasma was flowed in for two minutes at 5 AL min-
1, and then flow was stopped.  Clotting initiated where the channel walls were coated 
with lipid-TF and propagated into the section of the channel coated with inert lipids.  To 
measure the rate of propagation, the fluorescence intensity along the length of the channel 
(dashed red line, Figure S1a) was measured in 2.5 minute intervals, and the intensity 
profile in each image was measured and normalized by using MATLAB® (Figure S1b, 
also see Figure 1 of main text).   
 
Figure S1. 
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Characterization of the velocity of propagation of clotting in the absence of flow.  (a) 
Time-lapse images at two stage positions were acquired and aligned (open white arrow) 
by using MetaMorph®.  The fluorescence intensities at each time-point were measured 
along the length of the channel (long-dashed red line). (b) Time-lapse fluorescence 
intensity profiles of propagation of clotting.  Five minute intervals are shown here for 
clarity, while original data was acquired at 2.5 min intervals. The indicated time-points 
correspond to the images shown in panel a, and the open black arrow points out a minor 
defect in the intensity profile where the two images were aligned (corresponds to the 
open white arrow in panel a).  These intensity profiles were converted into the distance 
vs. time plot shown in Figure 1d of the main text by measuring the distance between each 
intensity profile at 50 percent maximum intensity (dashed line).  
 
Determining front velocity in the absence of flow in glass capillaries coated with 
thrombomodulin at 37 ºC. The rate of propagation of clotting in circular glass 
capillaries (530 µm inner diameter) coated with thrombomodulin (TM) at 37 ºC was also 
determined.  The capillaries were first made hydrophilic by flowing a solution of 
“piranha” (3:1 sulfuric acid:hydrogen peroxide, WARNING: piranha reacts violently 
with organic substances, including all human tissues) for 20 min, followed by rinsing 
with deionized water.  To coat glass capillaries with TM, 250 µL of the vesicles of 
reconstituted TM were pulled through the capillary for 5 min, and the capillaries were 
then rinsed by pulling through 500 µL of TRIS buffer (20 mM TRIS-HCl, 100 mM NaCl, 
pH 7.5). Lipid-TF was patterned on one end of the capillary to serve as the initiation site 
for clotting.  The tip of the capillary was exposed to air, which removed the bilayer with 
reconstituted TM, and then the tip was touched to a drop of lipid-TF vesicles to fill in the 
exposed area.  The capillary was rinsed with TRIS buffer.  Lipid-TF (red fluorescence) 
could be seen on the glass surface only at the tip.  The capillary was filled with 
recalcified plasma from the non-TF end of the capillary and sealed at the ends with 
silicon grease.  Clotting initiated on the lipid-TF, and the rate of propagation was 
measured as in Figure S1.
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Measuring the activity of reconstituted TM. To measure the activity of TM on the 
PDMS and glass surfaces, the rate of protein C activation in the presence of thrombin was 
measured (Esmon, N.L., DeBault, L.E. & Esmon, C.T. J. Biol. Chem. 258 5548-5553, 
(1983)).  The concentration of activated protein C (aPC) was determined by using an 
aPC-sensitive fluorogenic peptide dye, Boc-Leu-Ser-Thr-Arg-MCA (Ohno, Y. et al. J. 
Biochem 90, 1387-1395 (1981)).  A solution containing 5 nM human thrombin, 800 nM 
human protein C, 0.1% bovine serum albumin, 5 mM CaCl2, 20 mM TRIS, and 100 mM 
NaCl (final pH 7.5) was prepared and immediately flowed into the PDMS channel or 
glass capillary.  The PDMS channel was maintained at room temperature during the 
experiment, and the glass capillary was maintained at 37 ºC.  The blue fluorescence 
intensity was measured every 3 min for up to 3 h.  The aPC production was determined 
based on Michaelis-Menton kinetics and known kinetics for the aPC fluorogenic dye 
(Ohno, Y. et al. J. Biochem 90, 1387-1395 (1981)) (Table S1).  Thrombin is known to 
activate protein C directly, and to slowly activate the aPC-sensitive fluorogenic dye.  
Thus, the background fluorescence was measured in control samples containing no TM 
and was subtracted from the measured fluorescence intensity in samples containing TM.   
 
Table S1. 
Quantification of activated protein C (aPC) production from Egg PC lipid coated surfaces with 
reconstituted thrombomodulin (TM).  Velocities of propagation of clotting (front velocity, Fv) are 
shown. 
Surface Temp. (°C) 
TM:Egg PC 
ratio 
Calculated Surface 
Density 
(pmol m-2)
aPC production 
(pmol min-1 m-2)
Front Velocity 
(7m min-1)
PDMS 25 N/A N/A N/A 20 
PDMS 25 1:75600 4 10 24 
PDMS 25 1:7560 40 5* 25 
Glass 37 N/A N/A N/A 41 
Glass 37 1:75600 4 0.3 ND 
Glass 37 1:7560 40 10 50 
*Saturation in TM concentration may have been reached (Tseng, P. Y., Jordan, S. W., 
Sun, X. L, & Chaikof, E. L. Biomaterials 27, 2768-2775 (2006)). 
N/A = Not applicable because no TM was present.  Data is shown only for the 
comparison of front velocities. 
ND = Not determined. 
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Performing numerical simulations of propagation of clotting in the absence of flow.  
All numerical simulations were performed by using Comsol Multiphysics® version 3.3 
(Stockholm, Sweden).  Two rate equations were used to numerically simulate the change 
in concentration of activator, Cact. These rate equations are based on previously 
described equations (Kastrup, C. J.; Runyon, M. K.; Shen, S.; Ismagilov, R. F. Proc. 
Natl. Acad. Sci. U. S. A. 103, 15747-15752 (2006)).  The rate of autocatalytic production 
of Cact was described by Eq. 1. 
 R1 = k1[Cact]2[C’] / (ksat[C]2 + 14) + b             (1) 
The rate of linear inhibition of Cact was described by Eq. 2. 
 R2 = k2[Cact] (2) 
Transport of Cact was modeled by using the convection-diffusion equation.  All solution 
phase species in the numerical simulation had diffusion coefficients of 5 x 10-11 m2s-1 
(Krasotkina, Y. V.; Sinauridze, E. I.; Ataullakhanov, F. I. Biochim. Biophys. Acta-Gen. 
Subj. 1474, 337-345 (2000)). 
 
A surface-bound inhibitor, Isurf, similar to thrombomoldulin was incorporated into the 
simulation according to the scheme shown in Figure S2. Cact binds to Isurf and the Cact:Isurf 
complex converts a solution phase precursor, I’sol, to a solution phase inhibitor, Isol, with a 
rate that was described by Eq. 3. 
 R3 = k3[I’sol][Isurf][Cact] / [I’sol] + Km3 (3)   
Isol inhibits Cact with a rate that was described by Eq. 4. 
 R4 = k4[Isol][Cact] / [Cact] + Km4 (4)  
The total rate of inhibition in the presence of Isurf  is the sum of R2 and R4 and was 
described by Eq. 5. 
 R5 = k2[Cact] + k4[Isol][Cact] / [Cact] + Km4 (5) 
 
The species and their initial concentrations are based on known proteases in the blood 
coagulation cascade.  C’ is similar to a proenzyme and is converted to its active form, 
Cact. The rate of removal of C’ = -R1. The initial [C’] = 1.4 x 10-6 M (Butenas, S.; van't 
Veer, C.; Mann, K. G. Blood. 94, 2169-2178 (1999)) and the initial [Cact] = 5 x 10-12 M 
(Butenas, S.; Orfeo, T.; Gissel, M. T.; Brummel, K. E.; Mann, K. G. J. Biol. Chem. 279,
S5
22875-22882 (2004)).  Propagation of clotting was initiated by setting the initial [Cact] =
35 x 10-9 M in a 200 x 200 Am2 plane at the end of the channel (see Figure 2 of the main 
text). I’sol is the precursor the solution phase inhibitor, Isol, and had initial [I’sol] = 100 x
10-9 M (Feistritzer, C.; Schuepbach, R. A.; Mosnier, L. O.; Bush, L. A.; Di Cera, E.; 
Griffin, J. H.; Riewald, M. J. Biol. Chem. 281, 20077-20084 (2006)).  I’sol is removed 
with a rate = -R3. Isol had an initial [I’sol] = 0 M.  Isurf had an initial [Isurf ] = 42 nM.  The 
surface [Isurf] was estimated by assuming a surface density of Isurf  = 42 pmol m-2 
(Feistritzer, C.; Schuepbach, R. A.; Mosnier, L. O.; Bush, L. A.; Di Cera, E.; Griffin, J. 
H.; Riewald, M. J. Biol. Chem. 281, 20077-20084 (2006) and Esmon, C. T. Faseb J. 9,
946-955 (1995)), which corresponds to 3.3 x10 -17 moles / wall.  This number of moles 
was assumed to fill a 1 Am thick boundary layer at the wall (total volume = 8 x 10-10 L).  
The diffusion coefficient of Isurf was set as 1 x 10-50 m2s-1 to localize Isurf to the channel 
walls during the timescale of the simulation. 
 
The parameters used in the rate equations were approximated from literature values: k1 =
1.93 x 1013 M-2 s-1 was derived by taking a known rate constant for an enzyme in the 
coagulation cascade (Kuharsky, A. L.; Fogelson, A. L. Biophys. J. 80, 1050-1074 (2001)) 
and dividing by the initiation concentration of C’; ksat = 1.5 x 1015 M-2 was chosen such 
that the maximum [Cact] generated was approximately 500 nM; b = 1 x 10-13 M s-1 was 
chosen as the baseline rate of production of Cact; k2 = 0.02 s-1(O'Brien, L. M.; Mastri, M.; 
Fay, P. J. Blood. 95, 1714-1720 (2000)); k3 = 3.4 x 108 M-1 s-1 was derived by multiplying 
a known rate constant k’3 = 0.17 s-1 (Fogelson, A. L.; Tania, N. Pathophysiol. Haemost. 
Thromb. 34, 91-108 (2005)) and the equilibrium constant, Keq = 2 x 109 M-1 (Esmon, C. 
T. Faseb J. 9, 946-955 (1995)); Km3 = 5 x 10-6 M (Esmon, C. T. Faseb J. 9, 946-955 
(1995)); k4 = 0.04 s-1 (Marlar, R. A.; Kleiss, A. J.; Griffin, J. H. Blood. 59, 1067-1072 
(1982)); and Km4 = 102 x 10-9 M (Varfaj, F.; Neuberg, J.; Jenkins, P. V.; Wakabayashi, 
H.; Fay, P. J. Biochem. J. 396, 355-362 (2006)). 
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Figure S2.
Schematic drawing of the reactions used in the numerical simulations.  Reactions shown 
in red were used to represent autocatalytic production and linear consumption.  These are 
the only two reactions that take place in the absence of a surface-bound inhibitor.  
Reactions shown in black were added to mimic a surface-bound inhibitor similar to 
thombomodulin.  R represents rate.  The rates for R2 and R4 are for inhibition of one 
molecule of Cact. See supporting text above for details. 
 
Performing numerical simulations of propagation of clotting in the presence of flow.  
To simulate front propagation in the presence of flow, the same two rate equations used 
to describe front propagation in the absence of flow and in the absence of a surface-
bound inhibitor were used.  Flow was modeled by using the incompressible Navier-
Stokes equation, and transport of Cact was modeled by using the convection-diffusion 
equation.  For the simulation with a shear rate above the threshold (& = 170 s-1), the 
initial flow velocity, V [m s-1], was set to 2.2 x 10-3 m s-1. For the simulation with a shear 
rate below the threshold (& = 10 s-1), the V was set to 1.3 x 10-4 m s-1.
Geometry and dimensions of the devices used in experiments where propagation of 
clotting at a junction in the presence of flow was monitored. 
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Figure S3. Schematic drawing showing the dimensions of the junction and “valve” 
regions in the devices used in experiments monitoring propagation of clotting through a 
junction in the presence of flow.  (a) Channel dimensions for experiment with a shear rate 
above the threshold at the junction and a shear rate below the threshold at the “valve”.  
(b) Channel dimensions for experiment with a shear rate below the threshold at the 
junction and a shear rate above the threshold at the “valve”. The overall device geometry 
has been previously described (Runyon, M. K.; Johnson-Kerner, B. L.; Kastrup, C. J.; 
Van Ha, T. G.; Ismagilov, R. F. J. Am. Chem. Soc. 129, 7014-7015 (2007)). All 
dimensions are given as height (h), width (w), and length (l). 
 
Characterizing shear rate at the junction and the “valve”. 
Table S2. Flow rates and shear rates for experiments shown in Figure 4 of the main text. 
Experiment 
Volumetric 
flow rate* 
(7L min-1)
Flow velocity 
junction 
(mm s-1)
Shear rate 
junction** 
(s-1)
Flow velocity 
“valve” 
(mm s-1)
Shear rate 
“valve”*** 
(s-1)
190/30 2.9 1.1 190 0.4 30 
30/190 0.5 0.8 30 2.4 190 
* This is the volumetric flow rate in the channel with the “valve”.  The input volumetric 
flow rate was four times larger. 
** Shear rate was calculated at the midpoint of the wall for flow in a rectangular channel 
(Nataraja.N & Lakshman.S. Indian Journal of Technology 10, 435-438 (1973)). 
*** Shear rate at the “valve” corresponds to the shear rate in the rectangular channel just 
above and below the “valve” (see Figure S3).  
 
Determining that clots at a junction remain active after a 10 min exposure to a shear 
rate above the threshold. To determine if clots remain active after a brief exposure to 
shear rate above the threshold, plasma was flowed into a device similar to that shown in 
Figure 5 of the main text, at a shear rate (& = 140 s-1) above the threshold, and clotting 
was initiated in the initiation channel as described previously (Runyon, M. K.; Johnson-
Kerner, B. L.; Kastrup, C. J.; Van Ha, T. G.; Ismagilov, R. F. J. Am. Chem. Soc. 129,
7014-7015 (2007)).  This clot propagated in the initiation channel in the absence of flow 
up to the junction.  After the clot reached the junction, a shear rate above the threshold 
(& = 140 s-1) was maintained for 11 min or 18 min (two independent experiments).  
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Then, the shear rate was reduced to below the threshold (& = 30 s-1), and propagation of 
clotting out of the junction was monitored. 
 
In both experiments, propagation of clotting into the down stream “valve” was observed 
approximately 3 min after the shear rate was reduced, suggesting that the clot at the 
junction remained active.  These experiments were performed under slightly different 
conditions than the rest of the experiments analyzing propagation of clotting in the 
presence of flow.  These differences were: 1) platelet rich plasma was used instead of 
normal pooled plasma; 2) the device had multiple down stream “valves”; and 3) the 
dimension of the flow channel were h = 200 Am and  w = 200 Am, instead of  h = 200 Am
and w = 100 Am.  Regardless of these differences, these results demonstrate that the clot 
at the junction remained active after exposure to a shear rate above the threshold for 11 
to18 min. 
 
Determining that slowed front propagation through a junction after a D-
phenylalanyl-L-prolyl-L-arginyl-chloromethyl ketone (PPACK) exposure is not due 
to PPACK adsorbing to and releasing from PDMS. To determine if PPACK adsorbs 
to and releases from PDMS, a solution of TRIS buffer (20 mM TRIS-HCl, 100 mM 
NaCl, pH 7.4) and a solution containing 40 mM CaCl2, 90 mM NaCl, and 3 AM PPACK 
were flowed into a device at flow rates of 17.2 AL min-1 and 5.7 AL min-1, respectively 
(Figure S4a). These solutions were flowed for 7.5 min and collected at the outlet 
(PPACK fraction).  The PPACK fraction was stored at 4°C until later use.  Next, the 
PPACK flow was stopped and a solution containing 40 mM CaCl2 and 90 mM NaCl was 
flowed into the device (Figure S4a).  This solution was collected at the outlet in 80 sec 
intervals (buffer fractions) and stored at 4°C until later use.  Thrombin activity was 
determined by combining 50 AL of a solution of thrombin (40 mM CaCl2, 90 mM NaCl, 
1 mg ml-1 BSA, and 2 nM thrombin), 50 AL of a solution containing Boc-Asp(OBzl)-Pro-
Arg-MCA (100 AM), and 10 AL of the fraction collected at the outlet of the device 
(Figure S4b).  The rate of cleavage of Boc-Asp(OBzl)-Pro-Arg-MCA was measured on a 
Tecan SafireIITM fluorimeter (Vex = 380 nm, Vem = 440 nm). 
 
S9
Figure S4.  
Slowed propagation of clotting to the “valve” after PPACK exposure is not due to 
PPACK adsorbing to PDMS. (a) Schematic showing the experimental procedure for 
determining if PPACK adsorbs to and releases from PDMS.  See supporting text above 
for details.  (b) Characterization of thrombin activity as a function of fraction number.  
For each data point, the average is shown and error bars represent the minimum and 
maximum values (n = 2).  Thrombin activity reaches 100 % by buffer fraction 3, which 
corresponds to 4 min after PPACK flow was stopped.  
